TechDogs-"Global Photoimmunotherapy Market Report 2022-2027 Featuring Prominent Players - Rakuten Medical, Shimadzu, Modulight, Steba Biotech, & Luzitin"

Marketing Technology

Global Photoimmunotherapy Market Report 2022-2027 Featuring Prominent Players - Rakuten Medical, Shimadzu, Modulight, Steba Biotech, & Luzitin

By PR Newswire

PR Newswire
Overall Rating

DUBLIN, Jan. 24, 2023 /PRNewswire/ -- The "Global Photoimmunotherapy Market by Therapeutic Area, End-user, and Region: Competition Forecast and Opportunities to 2027" report has been added to ResearchAndMarkets.com's offering.

The global photoimmunotherapy market is anticipated to witness robust CAGR in the forecast period, 2023-2027.

Factors such as the increasing prevalence of cancer worldwide, growing healthcare expenditure, and ongoing research and development activities to find novel cancer treatment therapies primarily drive the demand for the global photoimmunotherapy market.

The rise in the investments by the leading authorities to develop the healthcare infrastructure and hire skilled healthcare professionals and favorable government reimbursement policies are the other prominent factors that can accelerate the global photoimmunotherapy market growth over the next five years.

Increased Cancer Prevalence Worldwide Drives the Market Growth

Cancer is a major health concern and is a leading cause of death across the globe. According to World Health Organization, cancer accounted for nearly 10 million deaths in 2020. During cancer, there is the rapid creation of abnormal cells that grow beyond their usual boundaries and can invade the adjoining parts of the body and spread to other organs, and the process is called metastasis.

Some of the most common kinds of cancer are breast, lung, colon, rectum, and prostate cancers. In 2020, due to lung cancer, around 1.0 million deaths were observed. Similarly, for colon and rectum and liver cancer, the number of deaths in 2020 was 916000 and 830000.

Approximately 400 000 children develop cancer every year, and cervical cancer is the most common cancer in 23 countries. Cancer can be reduced through early detection and the right treatment and care of the patients. The majority of cancers can be cured if detected and treated early.

Photoimmunotherapy is the recently developed hybrid cancer therapy that directly kills cancer cells as well as produces a therapeutic host immune response. Conventional immunotherapies such as checkpoint inhibition, engineered T cells and suppressor cell depletion, and immune-activating cytokine therapy do not directly destroy the cancer cells and rely on activating the immune system.

Photoimmunotherapy selectively destroys the cancer cells, which releases cancer antigens from dying cancer cells. Therefore, the increased cancer incidence worldwide and the high mortality rate due to cancer are expected to bolster the global photoimmunotherapy market growth over the forecast period.

Favorable Government Policies Supports the Market Growth

The government of various countries are concerned with the growing number of cancer cases and are taking steps to lower the patient mortality rate due to cancer. They are providing financial support, reimbursing the cost incurred during the cancer treatment procedures, and funding cancer treatment research and development activities, among others.

For instance, in India, some of the steps taken by the government that can fund cancer treatment are Health Minister's Cancer Patient Fund, The Health Minister's Discretionary Grants, The Central Government Health Scheme (CGHS), National Health Protection Scheme and The Prime Minister's National Relief Fund.

Leading authorities of various countries are also promoting the adoption of novel technologies to treat cancer effectively. Massive support from the governments is making the market players invest and find new solutions for cancer treatment. Therefore, supportive government policies and the entry of new market players are expected to play a major role in boosting the global photoimmunotherapy market growth over the next five years.

Market Segmentation

United States is expected to hold a significant market share due to the early adoption of advanced technologies by the healthcare sector and the presence of major market players in the country.

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global photoimmunotherapy market.

  • Rakuten Medical, Inc.
  • Shimadzu Corporation
  • Modulight Corporation
  • Steba Biotech Ltd.
  • Luzitin SA

Report Scope

Photoimmunotherapy Market, by Therapeutic Area:

  • Head & Neck Cancer
  • Metastatic Melanoma
  • Others

Photoimmunotherapy Market, by End-user:

  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Biotechnology & Pharmaceutical Companies
  • Others

Photoimmunotherapy Market, by Region:

  • North America
  • Asia-Pacific
  • Europe
  • South America
  • Middle East & Africa

For more information about this report visit https://www.researchandmarkets.com/r/cqthf7

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/global-photoimmunotherapy-market-report-2022-2027-featuring-prominent-players---rakuten-medical-shimadzu-modulight-steba-biotech--luzitin-301729596.html

SOURCE Research and Markets

Liked what you read? Head to the TechDogs homepage to find the latest tech content infused with drama and entertainment. We've got ArticlesWhite PapersCase Studies, ReportsVideosTechNews and Events - the complete lot to help you Know Your World of Technology.

First published on Wed, Jan 25, 2023

Enjoyed what you read? Great news – there’s a lot more to explore!

Dive into our content repository of the latest tech news, a diverse range of articles spanning introductory guides, product reviews, trends and more, along with engaging interviews, up-to-date AI blogs and hilarious tech memes!

Also explore our collection of branded insights via informative white papers, enlightening case studies, in-depth reports, educational videos and exciting events and webinars from leading global brands.

Head to the TechDogs homepage to Know Your World of technology today!

Disclaimer - Reference to any specific product, software or entity does not constitute an endorsement or recommendation by TechDogs nor should any data or content published be relied upon. The views expressed by TechDogs' members and guests are their own and their appearance on our site does not imply an endorsement of them or any entity they represent. Views and opinions expressed by TechDogs' Authors are those of the Authors and do not necessarily reflect the view of TechDogs or any of its officials. While we aim to provide valuable and helpful information, some content on TechDogs' site may not have been thoroughly reviewed for every detail or aspect. We encourage users to verify any information independently where necessary.

Join The Discussion

Join Our Newsletter

Get weekly news, engaging articles, and career tips-all free!

By subscribing to our newsletter, you're cool with our terms and conditions and agree to our Privacy Policy.

  • Dark
  • Light